Gilead Sciences, Inc. (TSX:GILD)
Canada · Delayed Price · Currency is CAD 31.92
+0.51 (1.62%)
Oct 26, 2026, 3:49 PM EDT
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of CAD 275.86 billion as of October 26, 2026. Its market cap has increased by 31.16% in one year.
Market Cap
275.86B
Enterprise Value
305.69B
Revenue
43.25B
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 289.43M to 275.86B, an increase of 95,208.69%. That is a compound annual growth rate of 21.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 275.86B | 32.12% |
| Dec 31, 2025 | 208.80B | 26.06% |
| Dec 31, 2024 | 165.64B | 24.25% |
| Dec 29, 2023 | 133.31B | -8.53% |
| Dec 30, 2022 | 145.73B | 26.44% |
| Dec 31, 2021 | 115.26B | 23.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apotex Health | 7.34B |
| Curaleaf Holdings | 2.92B |
| Extendicare | 2.64B |
| Sienna Senior Living | 2.28B |
| Green Thumb Industries | 1.93B |
| Cronos Group | 1.73B |
| Knight Therapeutics | 1.14B |
| WELL Health Technologies | 1.08B |